Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adenovirus Vaccine
100%
Helper-dependent Adenovirus
100%
Helper-dependent Adenoviral Vector
83%
Immune Response
66%
Evade
50%
HIV Vaccine
33%
Systemic Immunization
33%
Macaque
33%
Mucosal Surfaces
33%
Challenge Study
16%
Oral Immunotherapy
16%
HIV-1 Infection
16%
Increased Safety
16%
Genetic Engineering
16%
Systemic Immune Response
16%
Upstream Open Reading Frame (uORF)
16%
Immunization
16%
Immediate Needs
16%
Mucosal Vaccine
16%
Adenoviral
16%
Chemical Engineering
16%
SIV Challenge
16%
Pre-existing Immunity
16%
Mucosal Protection
16%
T Cells
16%
Barrier Protection
16%
Challenge Model
16%
Helper-dependent
16%
Intramuscular Immunization
16%
Oral Route
16%
Mucosal Response
16%
Vaccine Challenge
16%
Mucosal Challenge
16%
Enhanced Efficacy
16%
Vaccine Trial
16%
Mouse Model
16%
Immunology and Microbiology
Adenovirus Vaccine
100%
Helper Dependent Adenoviral Vector
100%
Human Immunodeficiency Virus
100%
Immune Response
71%
Simian Immunodeficiency Virus
57%
Serotype
42%
Poly(ethylene Glycol)
28%
Macaca
28%
Polyethylene Glycol
28%
HIV Vaccine
28%
Mouse Model
14%
Infectious Disease
14%
Open Reading Frame
14%
Infection
14%
Human Immunodeficiency Virus 1
14%
T Cell
14%
Medicine and Dentistry
Helper Dependent Adenoviral Vector
100%
Human Immunodeficiency Virus
100%
Adenovirus Vaccine
100%
Immune Response
71%
Simian immunodeficiency virus
57%
Serotype
42%
Mucosal Surface
28%
Polyethylene Glycol
28%
Human Immunodeficiency Virus Vaccine
28%
T Cell
14%
Open Reading Frame
14%
Side Effect
14%
Human Immunodeficiency Virus 1 Infection
14%
Oral
14%
Genetics
14%